๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The management of hypercalcemia of malignancy

โœ Scribed by Harold A. Harvey

Publisher
Springer-Verlag
Year
1995
Tongue
English
Weight
648 KB
Volume
3
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Humoral hypercalcemia of malignancy
Humoral hypercalcemia of malignancy
โœ K.W. Ng; T.J. Martin ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 556 KB

Studies on humoral hypercalcemia of malignancy have shown that tumors produce a protein that acts through the parathyroid hormone (PTH) receptor but is immunologically distinct from PTH. We have recently purified and cloned a parathyroid hormone-related protein (PTHrP) from a human lung cancer cell

Mechanisms of hypercalcemia in malignanc
Mechanisms of hypercalcemia in malignancy
โœ Anatole Besarab; Jose F. Caro ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 995 KB
Humoral hypercalcemia of malignancy: Som
Humoral hypercalcemia of malignancy: Some enigmas on the clinical features
โœ Kyoji Ikeda; Etsuro Ogata ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 783 KB

Humoral hypercalcemia of malignancy (HHM) is a common paraneoplastic syndrome mediated by tumor-derived parathyroid hormone-related peptide (PTHRP), which bears structural and functional similarities to PTH. Thus the clinical features of HHM are very similar to those of primary hyperparathyroidism

Effect of salmon calcitonin and etidrona
Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy
โœ Shireen Fatemi; Frederick R. Singer; Robert K. Rude ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 455 KB

Hypercalcemia of malignancy is a commonly encountered serious clinical problem that often requires aggressive therapy. In order to combine the rapid hypocalcemic effects of calcitonin with the more delayed effect of a bisphosphonate, we administered etidronate, 7.5 mg/kg/day intravenously and salmon